Strand Genomics And MediBiC Form Business Partnership
10/19/2005 5:11:25 PM
Strand Genomics, a global life sciences informatics company and MediBIC (TSE: 2369), a leading Japanese pharmacogenomics and pharmaceutical consulting firm announced today the formation of a business partnership to provide bioinformatics and data mining solutions in Japan.
Under the terms of the business agreement, MediBIC and Strand will jointly develop products and technologies for their drug discovery and development customers. They will offer products along with customization services, and provide consulting in the areas of genomics, proteomics, clinical studies, predictive ADME/Toxicology, and other pharmaceutical R and D areas.
MediBIC is a bio-venture company that provides various solutions for successful pharmaceutical R and D and medical advancement through genomics and informatics technologies.
comments powered by